CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for hVIVO PLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

hVIVO PLC
40 Bank Street, Floor 24, NaN
Phone: +44 2077561300p:+44 2077561300 LONDON, ENG  E14 5NR  United Kingdom Ticker: HVOHVO

Business Summary
hVIVO plc is a United Kingdom-based purpose-built, full-service international clinical development partner and engaged in human challenge trials serving biopharma companies. The Company has an end-to-end platform designed to bring important medicines to patients faster: spanning preclinical strategy, first in human studies, Phase II patient trials and specialist laboratory services, delivered through a participant database, wholly owned sites and laboratories across the UK and Germany. The Company offers integrated service lines which include consulting, clinical trials, human challenge trials, and laboratories. Its consulting provides preclinical and clinical strategy, encompassing non-clinical, clinical, CMC, pharmacokinetics, data management, biostatistics, and regulatory support to guide trial design, execution, and interpretation. The Company is also focused on Phase I/II clinical studies, particularly in dermatology and women's health.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/202612/31/2025Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Non-Executive Chairman of the Board Shaun E.Chilton 59 9/1/2025 9/1/2025
Chief Executive Officer, Executive Director YaminMohammed Khan 57 2/24/2022 10/13/2021
Chief Financial Officer, Executive Director StephenPinkerton 63 10/18/2022 10/18/2022
3 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
CRS Clinical Research Services Berlin GmbH Siemensdamm 65 Berlin Germany
Cryo Store Ltd 10 Queen St Place London United Kingdom

Business Names
Business Name
Cardinal Systems SAS
CRS Clinical Research Services Berlin GmbH
Cryo Store Ltd
7 additional Business Names available in full report.

General Information
Number of Employees: 376 (As of 12/31/2025)
Outstanding Shares: 688,401,079 (As of 6/30/2026)
Stock Exchange: LON


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, October 5, 2026